Education

Ph.D, Ottawa, Canada, 2008

Current position

Assistant professor, Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Iran

Publications

1. Saffarzadeh, F., Eslamizade, M. J., Mousavi, S. M., Abraki, S. B., Hadjighassem, M. R. and Gorji, A. (2016). TRPV1 receptors augment basal synaptic transmission in CA1 and CA3 pyramidal neurons in epilepsy. Neuroscience 314: 170-178.
2. Hashemi, M., Fallah, A., Aghayan, H. R., Arjmand, B., Yazdani, N., Verdi, J., Ghodsi, S. M., Miri, S. M. and Hadjighassem, M. (2016). A New Approach in Gene Therapy of Glioblastoma Multiforme: Human Olfactory Ensheathing Cells as a Novel Carrier for Suicide Gene Delivery. Mol Neurobiol 53(8): 5118-5128.
3. Hadjighassem, M., Kamalidehghan, B., Shekarriz, N., Baseerat, A., Molavi, N., Mehrpour, M., Joghataei, M. T., Tondar, M., Ahmadipour, F. and Meng, G. Y. (2015). Oral consumption of alpha-linolenic acid increases serum BDNF levels in healthy adult humans. Nutr J 14: 20.
4. Saffarzadeh, F., Eslamizade, M. J., Ghadiri, T., Modarres Mousavi, S. M., Hadjighassem, M. and Gorji, A. (2015). Effects of TRPV1 on the hippocampal synaptic plasticity in the epileptic rat brain. Synapse 69(7): 375-383.
5. Alizadeh, R., Hassanzadeh, G., Soleimani, M., Joghataei, M. T., Siavashi, V., Khorgami, Z. and Hadjighassem, M. (2015). Gender and age related changes in number of dopaminergic neurons in adult human olfactory bulb. J Chem Neuroanat 69: 1-6.
6. Eftekhari, S., Mehrabi, S., Soleimani, M., Hassanzadeh, G., Shahrokhi, A., Mostafavi, H., Hayat, P., Barati, M., Mehdizadeh, H., Rahmanzadeh, R., Hadjighassem, M. R. and Joghataei, M. T. (2014). BDNF modifies hippocampal KCC2 and NKCC1 expression in a temporal lobe epilepsy model. Acta Neurobiol Exp (Wars) 74(3): 276-287.
7. Mostafavi, H., Khaksarian, M., Joghataei, M. T., Soleimani, M., Hassanzadeh, G., Eftekhari, S., Soleimani, M., Mousavizadeh, K., Estiri, H., Ahmadi, S. and Hadjighassem, M. R. (2014). Selective beta2 adrenergic agonist increases Cx43 and miR-451 expression via cAMP-Epac. Mol Med Rep 9(6): 2405-2410.
8. Eftekhari, S., Mehvari Habibabadi, J., Najafi Ziarani, M., Hashemi Fesharaki, S. S., Gharakhani, M., Mostafavi, H., Joghataei, M. T., Beladimoghadam, N., Rahimian, E. and Hadjighassem, M. R. (2013). Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy. Epilepsia 54(1): e9-12.
9. Hadjighassem, M. R., Galaraga, K. and Albert, P. R. (2011). Freud-2/CC2D1B mediates dual repression of the serotonin-1A receptor gene. Eur J Neurosci 33(2): 214-223.
10. Hadjighassem, M. R., Austin, M. C., Szewczyk, B., Daigle, M., Stockmeier, C. A. and Albert, P. R. (2009). Human Freud-2/CC2D1B: a novel repressor of postsynaptic serotonin-1A receptor expression. Biol Psychiatry 66(3): 214-222.